
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 29.55 | 34.55 | 5.00 |
Shares | 29.94 | 30.15 | 0.21 |
Bonds | 39.98 | 39.99 | 0.01 |
Convertible | 0.01 | 0.01 | 0.00 |
Other | 0.52 | 0.52 | 0.00 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 11.64 | 16.19 |
Price to Book | 1.39 | 2.41 |
Price to Sales | 0.82 | 1.81 |
Price to Cash Flow | 6.21 | 9.83 |
Dividend Yield | 3.60 | 2.49 |
5 Years Earnings Growth | 8.38 | 10.65 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 24.25 | 11.86 |
Industrials | 17.70 | 12.37 |
Consumer Cyclical | 14.41 | 11.89 |
Basic Materials | 12.54 | 7.06 |
Communication Services | 12.34 | 7.53 |
Technology | 7.02 | 18.92 |
Financial Services | 6.59 | 16.46 |
Consumer Defensive | 3.08 | 7.49 |
Energy | 1.15 | 4.88 |
Real Estate | 0.77 | 2.79 |
Utilities | 0.16 | 3.21 |
Number of long holdings: 44
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Spain 3.45 31-Oct-2034 | ES0000012N35 | 7.58 | 103.160 | +0.60% | |
Spain 3.9 30-Jul-2039 | ES0000012L60 | 7.58 | 104.290 | -0.11% | |
Spain (Kingdom of) 2.07% | ES0L02506068 | 7.58 | - | - | |
Spain .85 30-Jul-2037 | ES0000012I24 | 7.58 | 75.070 | -0.50% | |
Spain (Kingdom of) 2.07% | ES0L02601166 | 7.58 | - | - | |
Spain 1.25 31-Oct-2030 | ES0000012G34 | 7.58 | 93.380 | -0.46% | |
Brightgate-Iapetus Equity I FI | ES0183798018 | 3.01 | - | - | |
Bluenote Global Equity FI | ES0108525009 | 2.90 | 19.647 | -0.07% | |
FvS Multiple Opportunities II HT | LU1748854947 | 2.84 | - | - | |
JPMorgan Investment Funds - Global Macro Opportuni | LU0248010471 | 2.80 | 112.350 | +0.16% |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review